Pharmacokinetic study of STN1012600 ophthalmic solution in healthy adult males volunteers

JRCT ID: jRCT2051230035

Registered date:08/06/2023

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: open angle glaucoma (OAG) or ocular hypertension (OHT)
• Date of first enrollment: 11/06/2023
• Target sample size: 8
• Study type: Interventional
• Intervention(s): STN1012600 ophthalmic solution 0.002%, 1 drop once daily for 7 days

Outcome(s)

• Primary Outcome: Plasma pharmacokinetics

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: <= 35age old
• Gender: Male
• Include criteria: Subjects who can comply with scheduled visits and the examination and observation as specified in the clinical study protocol

Exclude criteria

1)Subjects have a disease and/or abnormal laboratory value which is considered inappropriate from safety evaluation perspective
2)Subjects who are inappropriate as participants in this study in the opinion of the investigator or sub investigator

Related Information

• Primary Sponsor: Koji Oka